This might be related to the activation of multiple signaling pathways, such as Akt, in DLBCL tumor cells, leading to the overexpression of BCL2 family anti-apoptotic proteins [83–85]. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.